PubRank

K Arnold Chan

Author PubWeight™ 102.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 2005 6.20
2 Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004 5.25
3 Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006 5.16
4 Prescription drug use in pregnancy. Am J Obstet Gynecol 2004 4.92
5 ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011 3.12
6 Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008 2.82
7 ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011 2.77
8 Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003 2.73
9 The new Sentinel Network--improving the evidence of medical-product safety. N Engl J Med 2009 2.73
10 Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology 2012 2.63
11 The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 2008 2.60
12 Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004 2.29
13 Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003 2.19
14 The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007 2.16
15 Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007 2.03
16 Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev 2007 1.94
17 FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf 2006 1.83
18 Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006 1.73
19 Reduction in antibiotic use among US children, 1996-2000. Pediatrics 2003 1.71
20 Long-term statin use and psychological well-being. J Am Coll Cardiol 2003 1.66
21 Validity of gout diagnoses in administrative data. Arthritis Rheum 2007 1.62
22 Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care 2006 1.60
23 Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf 2014 1.52
24 Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. Antimicrob Agents Chemother 2010 1.51
25 Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm 2006 1.46
26 Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiol Drug Saf 2012 1.46
27 Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients. Ann Pharmacother 2006 1.42
28 Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007 1.35
29 Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics 2004 1.28
30 Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf 2007 1.27
31 Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005 1.23
32 Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc 2005 1.22
33 Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol 2002 1.19
34 Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 2011 1.18
35 Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol 2005 1.13
36 Pooling overdispersed binomial data to estimate event rate. BMC Med Res Methodol 2008 1.12
37 A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf 2008 1.09
38 Medication adherence and use of generic drug therapies. Am J Manag Care 2009 1.08
39 Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 2005 1.07
40 Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 2007 1.04
41 Potential drug-drug interactions in the outpatient setting. Med Care 2006 0.96
42 Gastric and duodenal safety of daily alendronate. Arch Intern Med 2002 0.94
43 Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf 2006 0.94
44 Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol 2006 0.92
45 Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors. Pharmacoepidemiol Drug Saf 2004 0.90
46 Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005 0.89
47 The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: a meta-analysis. Lung Cancer 2008 0.89
48 Active influenza vaccine safety surveillance: potential within a healthcare claims environment. Med Care 2009 0.86
49 Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs 2009 0.86
50 Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Ann Pharmacother 2007 0.85
51 Algorithms for identification of Guillain-Barré Syndrome among adolescents in claims databases. Vaccine 2013 0.84
52 Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care database. Pharmacotherapy 2013 0.84
53 Signal detection in pharmacovigilance: empirical evaluation of data mining tools. Pharmacoepidemiol Drug Saf 2005 0.84
54 Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf 2009 0.84
55 Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf 2008 0.83
56 Hormone therapy initiation after the Women's Health Initiative. Menopause 2008 0.83
57 The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative. J Gen Intern Med 2005 0.82
58 Identification of patients with Churg-Strauss syndrome (CSS) using automated data. Pharmacoepidemiol Drug Saf 2004 0.78
59 Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants. BMC Pediatr 2005 0.77
60 Topiramate use during pregnancy and major congenital malformations in multiple populations. Birth Defects Res A Clin Mol Teratol 2015 0.77
61 An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents. Med Decis Making 2011 0.77
62 Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf 2007 0.77
63 Liver function testing in patients on HMG-CoA reductase inhibitors. Pharmacoepidemiol Drug Saf 2003 0.76
64 Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatr 2006 0.75
65 Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. Pharmaceutics 2013 0.75
66 Identification of seizures among adults and children following influenza vaccination using health insurance claims data. Vaccine 2013 0.75
67 Evidence-based consensus development and reduction of rate of endoscopic thoracic sympathectomy: a national study. Dermatol Surg 2009 0.75
68 Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine 2013 0.75
69 Cost-effectiveness analysis of interferon-alpha therapy in the treatment of chronic hepatitis B in Taiwan. J Formos Med Assoc 2002 0.75
70 Multiple vaccinations and the risk of medically attended fever. Vaccine 2010 0.75